Cargando…
Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122542/ https://www.ncbi.nlm.nih.gov/pubmed/35596096 http://dx.doi.org/10.1007/s10067-022-06203-1 |
| _version_ | 1784711366736609280 |
|---|---|
| author | Barbhaiya, Medha Frey, Marianna B. Levine, Jonah Vitone, Gregory Lally, Lindsay Lockshin, Michael D. Bykerk, Vivian Feldman, Candace H. Mandl, Lisa A. |
| author_facet | Barbhaiya, Medha Frey, Marianna B. Levine, Jonah Vitone, Gregory Lally, Lindsay Lockshin, Michael D. Bykerk, Vivian Feldman, Candace H. Mandl, Lisa A. |
| author_sort | Barbhaiya, Medha |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9122542 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91225422022-05-21 Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City Barbhaiya, Medha Frey, Marianna B. Levine, Jonah Vitone, Gregory Lally, Lindsay Lockshin, Michael D. Bykerk, Vivian Feldman, Candace H. Mandl, Lisa A. Clin Rheumatol Letters of Biomedical and Clinical Research Springer International Publishing 2022-05-20 2022 /pmc/articles/PMC9122542/ /pubmed/35596096 http://dx.doi.org/10.1007/s10067-022-06203-1 Text en © The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR) 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letters of Biomedical and Clinical Research Barbhaiya, Medha Frey, Marianna B. Levine, Jonah Vitone, Gregory Lally, Lindsay Lockshin, Michael D. Bykerk, Vivian Feldman, Candace H. Mandl, Lisa A. Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City |
| title | Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City |
| title_full | Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City |
| title_fullStr | Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City |
| title_full_unstemmed | Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City |
| title_short | Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City |
| title_sort | modification of immunomodulatory medications by rheumatology patients during the peak of the covid-19 pandemic in new york city |
| topic | Letters of Biomedical and Clinical Research |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122542/ https://www.ncbi.nlm.nih.gov/pubmed/35596096 http://dx.doi.org/10.1007/s10067-022-06203-1 |
| work_keys_str_mv | AT barbhaiyamedha modificationofimmunomodulatorymedicationsbyrheumatologypatientsduringthepeakofthecovid19pandemicinnewyorkcity AT freymariannab modificationofimmunomodulatorymedicationsbyrheumatologypatientsduringthepeakofthecovid19pandemicinnewyorkcity AT levinejonah modificationofimmunomodulatorymedicationsbyrheumatologypatientsduringthepeakofthecovid19pandemicinnewyorkcity AT vitonegregory modificationofimmunomodulatorymedicationsbyrheumatologypatientsduringthepeakofthecovid19pandemicinnewyorkcity AT lallylindsay modificationofimmunomodulatorymedicationsbyrheumatologypatientsduringthepeakofthecovid19pandemicinnewyorkcity AT lockshinmichaeld modificationofimmunomodulatorymedicationsbyrheumatologypatientsduringthepeakofthecovid19pandemicinnewyorkcity AT bykerkvivian modificationofimmunomodulatorymedicationsbyrheumatologypatientsduringthepeakofthecovid19pandemicinnewyorkcity AT feldmancandaceh modificationofimmunomodulatorymedicationsbyrheumatologypatientsduringthepeakofthecovid19pandemicinnewyorkcity AT mandllisaa modificationofimmunomodulatorymedicationsbyrheumatologypatientsduringthepeakofthecovid19pandemicinnewyorkcity |